Prosecution Insights
Prosecution Insights
Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
AxiomBio, Inc. has 1 pending office action in the Semiconductors, Circuits & Optics technology area. The prosecution of this matter is handled by a distinct examiner in a distinct art unit. This indicates a specific and limited engagement with the patent office at this time, focusing resources on an individual filing. The company's current strategy in the Semiconductors, Circuits & Optics field is tied to the progress of this individual application.
The busiest examiner for AxiomBio, Inc. is NGUYEN, LAM S, who is responsible for 1 pending office action. This action constitutes the whole of the company's active workload, placing the outcome of current prosecution in the hands of an official. Because the total volume of active matters is low, the company's patenting trajectory is highly dependent on the decisions made by NGUYEN, LAM S within the assigned art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, LAM S | 1 | 78.8% | +0.2% |
| Art Unit | Apps |
|---|---|
| 2853 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19322222 | OPTIMIZING MOLECULE TOXICITY BY REPLACING TARGET FRAGMENTS WITH BIOISOSTERES | NGUYEN, LAM S | 2853 | §103 | Final Rejection | 63d | Pending | Sep 08, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial